Matches in Nanopublications for { ?s ?p "[Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_assertion description "[Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_provenance.
- NP1260899.RA0voHzUC0PNItSO1UTiPnXW2FhGn-cg4uMxJ2wdsyYbY130_assertion description "[Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260899.RA0voHzUC0PNItSO1UTiPnXW2FhGn-cg4uMxJ2wdsyYbY130_provenance.